Acute blood pressure elevation associated with biological therapies for cancer: a focus on VEGF signaling pathway inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute blood pressure elevation associated with biological therapies for cancer: a focus on VEGF signaling pathway inhibitors

Published:2019-04-08 Issue:5 Volume:19 Page:433-442
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Pucci Giacomo¹²^ORCID,Milan Alberto³,Paini Anna⁴,Salvetti Massimo⁴,Cerasari Alberto¹²,Vaudo Gaetano¹²

Affiliation:

1. Department of Medicine, University of Perugia, Perugia, Italy

2. Unit of Internal Medicine, Terni University Hospital, Terni, Italy

3. Department of Medical Sciences – Hypertension Center, University of Torino – AOU Città della Salute e della Scienza di Torino, Torino, Italy

4. Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

Funder

funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1594770

Reference100 articles.

1. 2018 ESC/ESH Guidelines for the management of arterial hypertension

2. Definitions and Epidemiological Aspects of Hypertensive Urgencies and Emergencies

3. Hospital and out-of-hospital mortality in 670 hypertensive emergencies and urgencies

4. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists;Cancer Treatment Reviews;2024-04

2. Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage;Frontiers in Pharmacology;2024-02-09

3. Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models;2024

4. Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models;2024

5. Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors;Life;2023-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3